CLINICAL_TRIALS
trial_result
· 2018-12-06
Clinical Trial Update: Everolimus in Treating Patients With Newly Diagnosed Localized Prostate Cancer [Phase 2]
Summary
Phase 2 clinical trial updating the use of everolimus in newly diagnosed localized prostate cancer; study terminated with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jorge A. Garcia, MD | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2018-12-06